Health Catalyst, Inc. - Common Stock, $0.01 par value (HCAT)

CUSIP: 42225T107

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / Common Stock, $0.01 par value
Shares outstanding
73,581,273
Total 13F shares
33,977,864
Share change
+6,896,053
Total reported value
$991,115,334
Put/Call ratio
33%
Price per share
$29.17
Number of holders
127
Value change
+$212,900,758
Number of buys
99
Number of sells
29

Quarterly Holders Quick Answers

What is CUSIP 42225T107?
CUSIP 42225T107 identifies HCAT - Health Catalyst, Inc. - Common Stock, $0.01 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Health Catalyst, Inc. - Common Stock, $0.01 par value (HCAT) as of Q2 2020

As of 30 Jun 2020, Health Catalyst, Inc. - Common Stock, $0.01 par value (HCAT) was held by 127 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 33,977,864 shares. The largest 10 holders included NORWEST VENTURE PARTNERS XI, LP, NORWEST VENTURE PARTNERS XII, LP, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., Capital Research Global Investors, ALLIANCEBERNSTEIN L.P., Clearbridge Investments, LLC, JANUS HENDERSON GROUP PLC, and Capital International Investors. This page lists 127 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.